Skip to main content
. 2023 Sep 14;29(10):2593–2601. doi: 10.1038/s41591-023-02572-5

Extended Data Table 2.

Most frequent (in more than 10% of patients) adverse events in the modified full analysis set (N = 62)

graphic file with name 41591_2023_2572_Tab2_ESM.jpg